Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain
CompletedPhase 4NCT01302275
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this trial is to determine if the effect of oxcarbazepine on chronic peripheral nerve pain depends on the supposed mechanism of the pain, ie. if oxcarbazepine mainly relieve pain in patients with irritable nerves.
Study details
- Official title
- Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain: Predictors of Response - a Randomised, Double-blind, Placebo-controlled Clinical Trial
- Conditions
- Polyneuropathy
- Peripheral Nerve Injury
- Postherpetic Neuralgia
- Interventions
- Drug: Oxcarbazepine
- Sponsor
- Søren H. Sindrup
- Collaborators
- Danish Pain Research Center; Innovative Medicines Initiative
- Organization
- Odense University Hospital
- Start date
- 2011-02
- Primary completion
- 2013-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Denmark
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * age \> 18 years old * definite or probable neuropathic pain * diagnosis of polyneuropathy, postherpetic neuralgia or peripheral nerve inju * pain duration \> 3 months * pain rating at baseline \>= 4 point NRS * Informed consent Exclusion Criteria: * other non-neuropathic pain condition * allergy to oxcarbazepine * renal or hepatic impairment * epilepsy * depression and other serious psychiatric disorders * serious medical condition * previous treatment for neuropathic that cannot be stopped * pregnancy * patients expected not to be able to comply with study protocol * treatment with anticonvulsants, antidepressant or opioids
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01302275